NCT04526665ELATIVEPBCElafibranorelafibranor-treated
…olerated in patients with PBC in the phase III ELATIVE® trial ( NCT04526665). Here, longitudinal protein expression profiles were evaluated…
1articles mentioning institutions
2institution mentions
1distinct institutions extracted
0%of mentions human-reviewed
Active filtersEntity: ELATIVE ×
ELATIVE
This institution is selected. Its supporting articles are shown below.